You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial
|
|---|---|
| Published in |
The Lancet, February 2010
|
| DOI | 10.1016/s0140-6736(09)61962-0 |
| Pubmed ID | |
| Authors |
Willemien A Nienhuis, Ymkje Stienstra, William A Thompson, Peter C Awuah, K Mohammed Abass, Wilson Tuah, Nana Yaa Awua-Boateng, Edwin O Ampadu, Vera Siegmund, Jan P Schouten, Ohene Adjei, Gisela Bretzel, Tjip S van der Werf |
| Abstract |
Surgical debridement was the standard treatment for Mycobacterium ulcerans infection (Buruli ulcer disease) until WHO issued provisional guidelines in 2004 recommending treatment with antimicrobial drugs (streptomycin and rifampicin) in addition to surgery. These recommendations were based on observational studies and a small pilot study with microbiological endpoints. We investigated the efficacy of two regimens of antimicrobial treatment in early-stage M ulcerans infection. |
Mendeley readers
The data shown below were compiled from readership statistics for 195 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Netherlands | 2 | 1% |
| Colombia | 1 | <1% |
| France | 1 | <1% |
| Belgium | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 189 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 31 | 16% |
| Researcher | 31 | 16% |
| Student > Master | 31 | 16% |
| Student > Bachelor | 25 | 13% |
| Other | 17 | 9% |
| Other | 29 | 15% |
| Unknown | 31 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 69 | 35% |
| Agricultural and Biological Sciences | 24 | 12% |
| Biochemistry, Genetics and Molecular Biology | 18 | 9% |
| Social Sciences | 10 | 5% |
| Immunology and Microbiology | 8 | 4% |
| Other | 28 | 14% |
| Unknown | 38 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 February 2012.
All research outputs
#7,355,930
of 25,373,627 outputs
Outputs from The Lancet
#24,482
of 42,669 outputs
Outputs of similar age
#43,757
of 172,974 outputs
Outputs of similar age from The Lancet
#105
of 173 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 42,669 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 67.9. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 172,974 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 173 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.